chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Asthma, Breath sounds abnormal, Bronchitis, Chest X-ray, Chest discomfort
Clinical narrative: Received Prevnar on 7/15/15 and Pneumovax on 9/16/15 recommended by doctor due to being severely IGA deficient even though I have multiple auto immune diseases.   On 9/28/15 started with cough, sleepy, slobbering and heavy chest.  Taking Robitusin & Mucinex DM with no results.  Oct 11, 2015 doctor prescribed Benzonatate and Methylprednisolone.  Renewed Benzonatate on Oct 20 & Nov 24 with still no relief.  Dec 1, started with fever.  Missed work on Dec 2, 3 & 4th.  Sleeping in recliner, persistent cough, fever for 6 days, squeaky door sound breathing.  Dec 7, doctor prescribed Dexcycycline Hyclate after chest xray and not sure of results but treating as pneumonia.  Jan 5, recheck xray and results still same and to get CT scan.  No airflow and cannot blow nose, nothing coming out.   Diagnosed as interstitial lung disease.  Jan 15, 2016  diagnosed as bronchial asthma and prescribed Advair and Fluticansone.  Also took Mucinex D with no results.  Feb 5, 2016, appt with pulmonologist.   4/8/19 diagnosed with Acute Bronchitis and lung nodule.   Prescibed ventolin first time in life and steroid.  Never had lung issues before these 2 vaccines.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Computerised tomogram, Condition aggravated, Cough, Drooling, Impaired work ability
Clinical narrative: Received Prevnar on 7/15/15 and Pneumovax on 9/16/15 recommended by doctor due to being severely IGA deficient even though I have multiple auto immune diseases.   On 9/28/15 started with cough, sleepy, slobbering and heavy chest.  Taking Robitusin & Mucinex DM with no results.  Oct 11, 2015 doctor prescribed Benzonatate and Methylprednisolone.  Renewed Benzonatate on Oct 20 & Nov 24 with still no relief.  Dec 1, started with fever.  Missed work on Dec 2, 3 & 4th.  Sleeping in recliner, persistent cough, fever for 6 days, squeaky door sound breathing.  Dec 7, doctor prescribed Dexcycycline Hyclate after chest xray and not sure of results but treating as pneumonia.  Jan 5, recheck xray and results still same and to get CT scan.  No airflow and cannot blow nose, nothing coming out.   Diagnosed as interstitial lung disease.  Jan 15, 2016  diagnosed as bronchial asthma and prescribed Advair and Fluticansone.  Also took Mucinex D with no results.  Feb 5, 2016, appt with pulmonologist.   4/8/19 diagnosed with Acute Bronchitis and lung nodule.   Prescibed ventolin first time in life and steroid.  Never had lung issues before these 2 vaccines.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Interstitial lung disease, Pneumonia, Pulmonary mass, Pyrexia, Scan with contrast
Clinical narrative: Received Prevnar on 7/15/15 and Pneumovax on 9/16/15 recommended by doctor due to being severely IGA deficient even though I have multiple auto immune diseases.   On 9/28/15 started with cough, sleepy, slobbering and heavy chest.  Taking Robitusin & Mucinex DM with no results.  Oct 11, 2015 doctor prescribed Benzonatate and Methylprednisolone.  Renewed Benzonatate on Oct 20 & Nov 24 with still no relief.  Dec 1, started with fever.  Missed work on Dec 2, 3 & 4th.  Sleeping in recliner, persistent cough, fever for 6 days, squeaky door sound breathing.  Dec 7, doctor prescribed Dexcycycline Hyclate after chest xray and not sure of results but treating as pneumonia.  Jan 5, recheck xray and results still same and to get CT scan.  No airflow and cannot blow nose, nothing coming out.   Diagnosed as interstitial lung disease.  Jan 15, 2016  diagnosed as bronchial asthma and prescribed Advair and Fluticansone.  Also took Mucinex D with no results.  Feb 5, 2016, appt with pulmonologist.   4/8/19 diagnosed with Acute Bronchitis and lung nodule.   Prescibed ventolin first time in life and steroid.  Never had lung issues before these 2 vaccines.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Somnolence
Clinical narrative: Received Prevnar on 7/15/15 and Pneumovax on 9/16/15 recommended by doctor due to being severely IGA deficient even though I have multiple auto immune diseases.   On 9/28/15 started with cough, sleepy, slobbering and heavy chest.  Taking Robitusin & Mucinex DM with no results.  Oct 11, 2015 doctor prescribed Benzonatate and Methylprednisolone.  Renewed Benzonatate on Oct 20 & Nov 24 with still no relief.  Dec 1, started with fever.  Missed work on Dec 2, 3 & 4th.  Sleeping in recliner, persistent cough, fever for 6 days, squeaky door sound breathing.  Dec 7, doctor prescribed Dexcycycline Hyclate after chest xray and not sure of results but treating as pneumonia.  Jan 5, recheck xray and results still same and to get CT scan.  No airflow and cannot blow nose, nothing coming out.   Diagnosed as interstitial lung disease.  Jan 15, 2016  diagnosed as bronchial asthma and prescribed Advair and Fluticansone.  Also took Mucinex D with no results.  Feb 5, 2016, appt with pulmonologist.   4/8/19 diagnosed with Acute Bronchitis and lung nodule.   Prescibed ventolin first time in life and steroid.  Never had lung issues before these 2 vaccines.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Decreased appetite, Fall, Fatigue, Headache, Loss of consciousness
Clinical narrative: It started with a headache the first day. By the second day, I had a severe fatigue, headache, and muscle aches. I was nauseous and had no appetite. This lasted two days. The third day, I felt a little better although I still had all symptoms. The fourth day, all of the symptoms increased in intensity and were especially bad that day and the next two. I ended up vomiting, and I passed out and fell one time. I spoke with the pharmacist on the sixth day, and he told me that all was pretty normal. On the eighth day, he suggested I see my PCP.   The doctor I saw, Dr., said I checked all of the symptom boxes. Today is the ninth day, and I am still nauseous and have muscle aches, especially in my knees.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Nausea, Neurological examination normal, Vomiting
Clinical narrative: It started with a headache the first day. By the second day, I had a severe fatigue, headache, and muscle aches. I was nauseous and had no appetite. This lasted two days. The third day, I felt a little better although I still had all symptoms. The fourth day, all of the symptoms increased in intensity and were especially bad that day and the next two. I ended up vomiting, and I passed out and fell one time. I spoke with the pharmacist on the sixth day, and he told me that all was pretty normal. On the eighth day, he suggested I see my PCP.   The doctor I saw, Dr., said I checked all of the symptom boxes. Today is the ninth day, and I am still nauseous and have muscle aches, especially in my knees.
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Blood test normal, Electroencephalogram normal, Generalised tonic-clonic seizure, Lumbar puncture normal, Pyrexia
Clinical narrative: FEVER AND THEN A TONIC CLONIC SEIZURE
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Urine analysis normal
Clinical narrative: FEVER AND THEN A TONIC CLONIC SEIZURE
Age: 16.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Pain, Pyrexia
Clinical narrative: FEVER OVER 101 AND INFLAMMATION, REDNESS AND TENDERNESS AT INJECTION SITE AS WELL AS BODY ACHES
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Borrelia test, Differential white blood cell count, Full blood count normal, Headache
Clinical narrative: Body aching Right arm discomfort soreness pain in antecubital inner aspect - continues to this date. Joint pain, nausea vomiting in AM neck discomfort, HA, feels like "flu" Feels like low grade fever. Patient statement, Pt stated she has been experiencing Joint pain in Antecubital area of Left arm. MMR vaccine was received on 7/2/19. Employee also stated arm pain, malaise, nausea, vomiting and feeling sick since 7/2/19. Employee did not contact Employee health regarding symptoms. Employee went to family doctor. PCP obtained Labs (CBC + platelets) which were normal. Employee stated see was screened for Lyme's disease also because last week she found a tick on her last week. It was not implanted. It has been almost 1 month since MMR vaccine.
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Influenza like illness, Limb discomfort, Malaise, Musculoskeletal discomfort, Nausea
Clinical narrative: Body aching Right arm discomfort soreness pain in antecubital inner aspect - continues to this date. Joint pain, nausea vomiting in AM neck discomfort, HA, feels like "flu" Feels like low grade fever. Patient statement, Pt stated she has been experiencing Joint pain in Antecubital area of Left arm. MMR vaccine was received on 7/2/19. Employee also stated arm pain, malaise, nausea, vomiting and feeling sick since 7/2/19. Employee did not contact Employee health regarding symptoms. Employee went to family doctor. PCP obtained Labs (CBC + platelets) which were normal. Employee stated see was screened for Lyme's disease also because last week she found a tick on her last week. It was not implanted. It has been almost 1 month since MMR vaccine.
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Pain, Pain in extremity, Platelet count normal, Pyrexia, Vomiting
Clinical narrative: Body aching Right arm discomfort soreness pain in antecubital inner aspect - continues to this date. Joint pain, nausea vomiting in AM neck discomfort, HA, feels like "flu" Feels like low grade fever. Patient statement, Pt stated she has been experiencing Joint pain in Antecubital area of Left arm. MMR vaccine was received on 7/2/19. Employee also stated arm pain, malaise, nausea, vomiting and feeling sick since 7/2/19. Employee did not contact Employee health regarding symptoms. Employee went to family doctor. PCP obtained Labs (CBC + platelets) which were normal. Employee stated see was screened for Lyme's disease also because last week she found a tick on her last week. It was not implanted. It has been almost 1 month since MMR vaccine.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: Sore Arm; Uncomfortable; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd March 2019, the patient received Shingrix (intramuscular) .5 ml. On an unknown date, 122 days after receiving Shingrix, the patient experienced pain in arm and arm discomfort. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the arm discomfort was unknown.   It was unknown if the reporter considered the pain in arm and arm discomfort to be related to Shingrix.  Additional case details were reported as follows: The vaccine lot number and expiry date was not readily available The patient received vaccine in left deltoid. The patient initially felt fine following vaccination but was now complaining her arm was sore described as being uncomfortable when trying to undo bra strap. The reporter unsure if sore arm was related to injury or vaccine. The reporter gave permission to follow up. This case had been linked to the case US2019133834, reported by same reporter. In the document outcome of events was reported as recovering, but in the database its mentioned as not recovered, so kept as reported in database.
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash; This case was reported by a physician via sales rep and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix  Additional information received were as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per vaccine indication. The doctor shared that the patient returned with a rash on the back of the neck after receiving a dose of Shingrix.  The reporter referred the patient to the dermatologist.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Eyelid ptosis, Neck pain, Swelling
Clinical narrative: neck pain; redness; swelling that went up her left side; eye droop; This case was reported by a nurse via sales rep and described the occurrence of neck pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th July 2019, the patient received the 1st dose of Shingrix. In July 2019, less than a week after receiving Shingrix, the patient experienced neck pain, erythema, swelling and ptosis. On an unknown date, the outcome of the neck pain, erythema, swelling and ptosis were unknown.   It was unknown if the reporter considered the neck pain, erythema, swelling and ptosis to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix on left side and went to the emergency room (ER) complaining of left side eye droop and neck pain. The patient also has redness and swelling that went up her left side. The patient was not sure if the events were related to the Shingrix and she would like any information regarding Shingrix in relation to Bell's palsy.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: vaccination site pain; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient age was over 70 years old. The age at vaccination was not reported. After vaccination with 1st dose, the patient experienced injection site pain for 2 days. The reporter agree to follow up. For the tollerence of 2nd dose, refere case US2019AMR136243.
Age: 18.0
Sex: M
Vaccine: MENB
Symptoms: Epistaxis, Fatigue, Injection site pain
Clinical narrative: nose bleed; fatigue; injection site tenderness; This case was reported by a consumer via call center representative and described the occurrence of injection site tenderness in a 18-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Concurrent medical conditions included multiple allergies.   On 1st July 2019, the patient received the 1st dose of Bexsero (intramuscular) .5 ml. On 1st July 2019, less than a day after receiving Bexsero, the patient experienced injection site tenderness. On 9th July 2019, the patient experienced epistaxis and fatigue. On 4th July 2019, the outcome of the injection site tenderness was recovered/resolved. On 10th July 2019, the outcome of the epistaxis and fatigue were recovered/resolved.   It was unknown if the reporter considered the injection site tenderness, epistaxis and fatigue to be related to Bexsero.  Additional details were provided as follows: This case was reported by the patient's mother. The reporter did not have the vaccine information for this adverse event (AE). The patient received a dose of Bexsero in his left arm and developed injection site tenderness that lasted for 3 days. 8 days after vaccination, the patient had nose bleed and fatigue, that lasted for 1 day. The reporter did not consent to follow-up and also did not consent to Health care professional (HCP) follow up for this case.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation
Clinical narrative: Vaccination site erythema; Vaccination site inflammation; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th July 2019, the patient received Shingrix. On 20th July 2019, less than a day after receiving Shingrix, the patient experienced injection site erythema and injection site inflammation. On an unknown date, the outcome of the injection site erythema and injection site inflammation were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema and injection site inflammation to be related to Shingrix.  Additional case details were reported as follows: The vaccine lot number and expiry date was not readily available The patient received vaccine in left deltoid. The patient experienced redness and inflammation at the injection site and also complains of it at the time of reporting being unresolved. The reporter stated she had observed this reaction with multiple undisclosed persons. The reporter gave permission to follow up. This case had been linked to the case US2019133826, reported by same reporter. In the XML document outcome of events was reported as recovering, but in database its mentioned as not recovered, so kept as reported in database.
Sex: F
Vaccine: VARZOS
Symptoms: Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: Sore Arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th July 2019, the patient received Shingrix. On 24th July 2019, less than a day after receiving Shingrix, the patient experienced pain in arm and injected limb mobility decreased. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the injected limb mobility decreased was unknown.   It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported, she just received Shingrix vaccine and her arm was really sore and it hurt when she moved arm. The patient asked remedy to relieve the pain. The call center representative gave medical disclaimer ending with referring to pharmacist or other healthcare professional for medical questions.  The patient agreed and abruptly disconnected the call. Therefore, information about patient demographics including spelling of first name, phone number and address, date of birth, vaccine facility details and suspect vaccine information was not collected.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: injection site redness; injection site hardness almost down to elbow; injection site soreness; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site induration and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site induration and injection site pain were recovered/resolved.   The reporter considered the injection site erythema, injection site induration and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the unknown deltoid. The patient stated that, 1st dose was given on 11th April 2019 or 12th April 2019, so entered as 11th April 2019. The patient stated that, within 24 hours of injection, the injection site became red, sore and hard almost down to her elbow. The patient stated that, the symptoms lasted over a week. The patient reported that, in the afternoon of the day of reporting, was scheduled for 2nd dose. There is discrepancy with time to onset as per narrative and reported field ,so considered least time to onset. The patient consented to follow up.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Generalised tonic-clonic seizure, Injection site bruising, Injection site pain
Clinical narrative: bad bruising at the injection site; pain at the injection site; episodes of grand mal seizure; Initial information received on 29-Jul-2019 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional (Patients mother).  This case involves a 11 years old female patient who experienced episodes of grand mal seizure, bad bruising at the injection site and pain at the injection site, while she received vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s), family history and concomitant medications were not provided.   On 16-Apr-2019, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number, expiry date, dose, dose in series, route and site of administration not reported).  On 26-Apr-2019, the patient experienced a serious grand mal seizure (generalised tonic-clonic seizure) 10 days following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.. It was reported that patient had two more episodes of the same event. This event was assessed as medically significant.  On an unknown date, the patient developed a non-serious bad bruising at the injection site (vaccination site bruising) and pain at the injection site (vaccination site pain) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  It was not confirmed that the vaccine was administered into the vein instead of deltoid muscle (the doctor thought that it might be).  No Lab data was reported.  Final diagnosis was episodes of grand mal seizure, pain at the injection site and bad bruising at the injection site.   An unknown corrective treatment was received (now on medication).  The event outcome was reported as Unknown for all the events.  Information on batch number was requested.  Documents held by the sender: none.; Sender's Comments: This case involves a 11 years old female patient who developed grand mal seizure 10 days after vaccination with MENACTRA and also presented with vaccination site bruising and vaccination site pain. Time to onset is compatible with the role of vaccine. However, further information including patient's medical history, concomitant medications, previous vaccination and tolerance, laboratory investigations excluding other etiology would be needed to fully assess this case. Based on available information the role of vaccine cannot be assessed.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Redness to site 12.5mm x 9 mm, hot to touch, hardening to left mid/lateral thigh
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Malaise, Pain, Pyrexia
Clinical narrative: Fever to 102.5, shaking chills, body aches, malaise, arthralgias
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Tremor
Clinical narrative: Fever to 102.5, shaking chills, body aches, malaise, arthralgias
Age: 16.0
Sex: M
Vaccine: HEP, HPV9, IPV, MENB, MMR, MNQ, TDAP, VARCEL
Symptoms: Dizziness postural, Fall, Hyperhidrosis, Pallor, Syncope
Clinical narrative: After receiving all of the above vaccines, client became dizzy and lightheaded upon standing and collapsed to the floor.  Able to return client to a chair, complained of ringing in his ears, he was also pale and diaphoretic.  Vitals - BP 90/68, temp. 96/1, pulse 60.  Client given some water to drink and a cold compress given for face and neck.  Client allowed to rest for about 20 mins and stated that he was fine and was able to walk out on his own.
Age: 16.0
Sex: M
Vaccine: HEP, HPV9, IPV, MENB, MMR, MNQ, TDAP, VARCEL
Symptoms: Tinnitus
Clinical narrative: After receiving all of the above vaccines, client became dizzy and lightheaded upon standing and collapsed to the floor.  Able to return client to a chair, complained of ringing in his ears, he was also pale and diaphoretic.  Vitals - BP 90/68, temp. 96/1, pulse 60.  Client given some water to drink and a cold compress given for face and neck.  Client allowed to rest for about 20 mins and stated that he was fine and was able to walk out on his own.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Decreased appetite, Lymphadenopathy, Malaise, Pruritus, Pyrexia
Clinical narrative: Developed Measles-like rash that made patient's eyes swell shut. Itching, malaise at 11 days post injection.   At 21 days post injection, patient developed a fever of 101 for 2 days, poor appetite, and swollen lymph nodes.   Treatment was Benadryl to try and decrease the rash and wait it out.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Rash morbilliform, Swelling of eyelid
Clinical narrative: Developed Measles-like rash that made patient's eyes swell shut. Itching, malaise at 11 days post injection.   At 21 days post injection, patient developed a fever of 101 for 2 days, poor appetite, and swollen lymph nodes.   Treatment was Benadryl to try and decrease the rash and wait it out.
Age: 13.0
Sex: M
Vaccine: HPV9, UNK
Symptoms: Blood glucose normal, Confusional state, Dysarthria, Lip injury, Syncope
Clinical narrative: patient fainted approx 5 minutes  after hpv given; sustained laceration to lower lip  was communicating within 1 minute of event, but was confused, with slurred speech
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Diplopia, Dizziness, Limb discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: right arm swelled to "2 times" size of left arm, dizziness, double vision, arm pain/heaviness. Began yesterday, symptoms have subsided some today. Advised patient to take Benadryl and have someone take her to urgent care for immediate evaluation and treatment.
Age: 4.0
Sex: U
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Full blood count, Urine analysis, Urticaria
Clinical narrative: Hives (urticaria) 1 1/2 - 2 hrs after vaccine - MMR/Varill/DTAP/IPV
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Dermatitis allergic, Injection site rash, Pain in extremity, Pruritus, Rash
Clinical narrative: Vaccine admin 7/23 Pt reported arm pain and a rash at injection site that also radiated around arm and some patches on neck on 7/24/19. Ibuprofen and cold compress were advised. The pt then reported an allergic rash throughout body with itching on 7/29/19. She was advised to get Benadryl and she made an appt at Dr office. She was given prednisone taper and clobetasol cream 7/31/19.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Skin lesion
Clinical narrative: Developed about 6 small skin lesions that are dark red in appearance with no other symptoms.
Age: 55.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Infection, Swelling, Tenderness
Clinical narrative: arm became red/tender/swollen, infection site was swollen 6 inches across by 5 inches high, patient was icing and started antihistamine
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Loss of consciousness, Pyrexia, Somnolence
Clinical narrative: Very tired, 102 Fiver, extreme headache, passed out and slept for 5 hours.,
Age: 5.0
Sex: M
Vaccine: MMRV
Symptoms: Blister rupture, Erythema, Full blood count normal, Rash, Scab
Clinical narrative: Vaccine given 6/17/19.  Started methylphenidate on 6/29.   Developed diffuse urticaria to torso with some raised wheals to all extremities on 6/30.  Went to ED and given orapred 15 mg x 1 and famotidine 20 mg PO x 1.  Home with orapred 15 mg/15 ml - 5 ml BID x 2 days; 2.5 mg BID x 2 days and then 1.5 ml BID x 2 days.  On 7/2, rash worse with multiple scattered erythematous areas to body including left flank, upper chest and upper back.  Appear to be ruptured blebs.  Crusting noted to lips.  No oral mucosa involvement.  Given benadryl 12.5 mg IV x 1; famotidine 20 mg IV x 1 and solumedrol 40 mg IV x 1.  Given IV fluids.  Transferred to hospital.
Age: 5.0
Sex: M
Vaccine: MMRV
Symptoms: Urine analysis normal, Urticaria
Clinical narrative: Vaccine given 6/17/19.  Started methylphenidate on 6/29.   Developed diffuse urticaria to torso with some raised wheals to all extremities on 6/30.  Went to ED and given orapred 15 mg x 1 and famotidine 20 mg PO x 1.  Home with orapred 15 mg/15 ml - 5 ml BID x 2 days; 2.5 mg BID x 2 days and then 1.5 ml BID x 2 days.  On 7/2, rash worse with multiple scattered erythematous areas to body including left flank, upper chest and upper back.  Appear to be ruptured blebs.  Crusting noted to lips.  No oral mucosa involvement.  Given benadryl 12.5 mg IV x 1; famotidine 20 mg IV x 1 and solumedrol 40 mg IV x 1.  Given IV fluids.  Transferred to hospital.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site pain, Pain
Clinical narrative: Injection site soreness, whole body aches/soreness. 12 hours after injection.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Induration, erythema, Warmth, tender (L) Deltoid.
Age: 62.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis (it was around 4-6 inches from injection site)
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Therapy non-responder
Clinical narrative: did not seroconvert; did not seroconvert/ blod work checked about a month ago, which showed no antibodies to measles; blod work checked about a month ago, which showed no antibodies to measles; This spontaneous report was received from a physician who was reporting on his wife, currently 43-year-old female patient. The patient's current conditions included colitis ulcerative and in vitro fertilisation (IVF) treatment. The patient had no concomitant therapies, drug reactions or allergies. On an unknown dates (reported as years ago), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, (exact doses, frequency, routes of administration, injection sites, lot # and expiration dates were not reported) several times due to being a healthcare provider and also due to receiving IVF treatment. The reporter stated that the patient did not seroconvert after measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and in approximately June 2019 (reported as about a month ago), the patient had her blood work checked, which showed no antibodies to measles. There were no treatments given for the events. The outcome of events was unknown. The relatedness between events and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.
Sex: U
Vaccine: HPV4, HPV9
Symptoms: Injection site pain, Vaccination site pain
Clinical narrative: discomfort with injection; Vaccine is painful; This literature marketed report was received from the bellow authors and refers to 13 adults patients of unspecofied age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  The study was conducted among both male and female, from 18 to 64 year old ,  undergraduate and graduate students at a large public university , they were selected as the study participants because of their constant exposure to the internet and technology. Quantitative data on the survey included questions that asked about  demographic characteristics, sexual health behaviors, knowledge of HPV, barriers to HPV uptake, and digital health technology practices.  Because of the descriptive nature of the survey, no inclusion and exclusion criteria were established. The survey was implemented using online software. Before data collection, the survey was pilot tested with a sample of undergraduate and graduate students (n = 81). Feedback provided from this sample was used to revise the survey for data collection, which was conducted over a period of 6 months.  On an unknown date, the patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) unidentified Merck hpv vaccine administered (name and lot number not provided) (dosage, frequency and route were not provided).  It was stated that one of the barriers to human pápillomavirus uptake was that the vaccin was painful and the discomfort with th einjection.  The outcome of the events were unknown.
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Ear pain, Fatigue, Headache, Joint stiffness
Clinical narrative: tiredness; joint ache; muscle ache; headache; Pain; hair ache / scalp hurts; Stiffness; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included bell's palsy.   On 12th March 2019, the patient received the 1st dose of Shingrix. On 13th March 2019, 1 days after receiving Shingrix, the patient experienced tiredness, joint pain, muscle pain, headache, ear pain, scalp pain and stiff joint. The patient was treated with paracetamol (Tylenol). On 15th March 2019, the outcome of the tiredness, joint pain, muscle pain, headache, ear pain, scalp pain and stiff joint were recovered/resolved.   It was unknown if the reporter considered the tiredness, joint pain, muscle pain, headache, ear pain, scalp pain and stiff joint to be related to Shingrix.  Additional information received were as follows: The patient received 1st dose of Shingrix on left arm. The day after vaccination, the patient experienced tiredness, joint pain with stiffness and soreness muscle ache, headache, hair ache, ear hurts, and scalp hurts which resolved after 2 days. For tolerance to 2nd dose of Shingrix, refer linked case US2019AMR140172.
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Pain of skin
Clinical narrative: tiredness; joint ache; muscle ache; headache; Pain; hair ache / scalp hurts; Stiffness; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included bell's palsy.   On 12th March 2019, the patient received the 1st dose of Shingrix. On 13th March 2019, 1 days after receiving Shingrix, the patient experienced tiredness, joint pain, muscle pain, headache, ear pain, scalp pain and stiff joint. The patient was treated with paracetamol (Tylenol). On 15th March 2019, the outcome of the tiredness, joint pain, muscle pain, headache, ear pain, scalp pain and stiff joint were recovered/resolved.   It was unknown if the reporter considered the tiredness, joint pain, muscle pain, headache, ear pain, scalp pain and stiff joint to be related to Shingrix.  Additional information received were as follows: The patient received 1st dose of Shingrix on left arm. The day after vaccination, the patient experienced tiredness, joint pain with stiffness and soreness muscle ache, headache, hair ache, ear hurts, and scalp hurts which resolved after 2 days. For tolerance to 2nd dose of Shingrix, refer linked case US2019AMR140172.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Cold sweat, Fatigue, Feeling hot, Headache
Clinical narrative: body ache; muscle ache; pain; Headache; tiredness; fever; Feeling hot; sweaty; feeling clammy; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 12th March 2019 and had not adverse events). Concurrent medical conditions included autoimmune disorder.   On 23rd July 2019, the patient received the 2nd dose of Shingrix. In July 2019, less than a week after receiving Shingrix, the patient experienced general body pain, muscle pain, joint pain, headache, tiredness, fever, feeling hot, sweating and clamminess. On an unknown date, the outcome of the general body pain, muscle pain, joint pain, headache, tiredness, fever, feeling hot, sweating and clamminess were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, muscle pain, joint pain, headache, tiredness, fever, feeling hot, sweating and clamminess to be related to Shingrix.  Additional information received were as follows: This case was reported by the patient's husband. The patient received 2nd dose of Shingrix on left arm. The patient experienced adverse events like body ache, muscle ache, joint pain, headache, tiredness, fever with hot and sweaty and feeling clammy. This case has been linked with US2019134786, reported by the same reporter.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperhidrosis, Myalgia, Pain, Pyrexia
Clinical narrative: body ache; muscle ache; pain; Headache; tiredness; fever; Feeling hot; sweaty; feeling clammy; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 12th March 2019 and had not adverse events). Concurrent medical conditions included autoimmune disorder.   On 23rd July 2019, the patient received the 2nd dose of Shingrix. In July 2019, less than a week after receiving Shingrix, the patient experienced general body pain, muscle pain, joint pain, headache, tiredness, fever, feeling hot, sweating and clamminess. On an unknown date, the outcome of the general body pain, muscle pain, joint pain, headache, tiredness, fever, feeling hot, sweating and clamminess were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, muscle pain, joint pain, headache, tiredness, fever, feeling hot, sweating and clamminess to be related to Shingrix.  Additional information received were as follows: This case was reported by the patient's husband. The patient received 2nd dose of Shingrix on left arm. The patient experienced adverse events like body ache, muscle ache, joint pain, headache, tiredness, fever with hot and sweaty and feeling clammy. This case has been linked with US2019134786, reported by the same reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Asthenia, Chills, Headache, Pain
Clinical narrative: Body aches; Body weakness; Right upper abdominal pain; Chills with shakes; Headache; SHAKES; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (4 times in life. Once in 1985 on right hip, once in 2017 in right eye, and twice in 2018) and corneal scar (had twice in 2018).   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a year after receiving Shingrix, the patient experienced general body pain, weakness generalized, upper abdominal pain, chills, headache and tremor. On an unknown date, the outcome of the general body pain, weakness generalized, upper abdominal pain, chills, headache and tremor were unknown.   It was unknown if the reporter considered the general body pain, weakness generalized, upper abdominal pain, chills, headache and tremor to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving vaccine the patient had body weakness, aches, right upper abdominal pain, chills with shakes, and a headache. The patient asked whether the provided information was helpful.
Sex: U
Vaccine: VARZOS
Symptoms: Tremor
Clinical narrative: Body aches; Body weakness; Right upper abdominal pain; Chills with shakes; Headache; SHAKES; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (4 times in life. Once in 1985 on right hip, once in 2017 in right eye, and twice in 2018) and corneal scar (had twice in 2018).   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a year after receiving Shingrix, the patient experienced general body pain, weakness generalized, upper abdominal pain, chills, headache and tremor. On an unknown date, the outcome of the general body pain, weakness generalized, upper abdominal pain, chills, headache and tremor were unknown.   It was unknown if the reporter considered the general body pain, weakness generalized, upper abdominal pain, chills, headache and tremor to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving vaccine the patient had body weakness, aches, right upper abdominal pain, chills with shakes, and a headache. The patient asked whether the provided information was helpful.
Age: 50.0
Sex: U
Vaccine: VARZOS
Symptoms: Adverse reaction
Clinical narrative: feel all the side effects; This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a 50-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd July 2019, the patient received Shingrix. On 23rd July 2019, 1 days after receiving Shingrix, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown.   It was unknown if the reporter considered the adverse reaction to be related to Shingrix.  Additional details were provided as follows: The patient had the vaccine 22nd July 2019 and feel all the side effects 23rd July 2019. The patient asked that is it ok to take ibuprofen and will help me feel better.
Sex: U
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: High fever; This case was reported by a consumer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th July 2019, the patient received the 1st dose of Shingrix. On 18th July 2019, 1 days after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. The patient received Shingrix and the following day the patient experienced high fever. The customer ended the chat before gathering information and not able to gather demographics or adverse event questions.
Age: 66.0
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Feeling abnormal, Pain, Pyrexia
Clinical narrative: Feel terrible/feel bad; Chills; Fever; Body aches; This case was reported by a consumer and described the occurrence of feeling bad in a 66-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first part of the vaccine did not effect).   On 23rd July 2019, the patient received the 2nd dose of Shingrix. On 23rd July 2019, less than a day after receiving Shingrix, the patient experienced feeling bad, chills, fever and general body pain. On an unknown date, the outcome of the feeling bad, chills, fever and general body pain were unknown.   It was unknown if the reporter considered the feeling bad, chills, fever and general body pain to be related to Shingrix.  Additional details were provided as follows: The first part of the vaccine shingrix did not affect the patient at all. The patient received the 2nd dose of shingrix at night and the patent felt terrible, had chills that turned in to a fever of 102.8 degrees F. On 24th July 2019, the patient felt bad body aches and fever dropped to about 99.8 degree F.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Malaise, Product supply issue
Clinical narrative: product supply issue; mildly sick; This case was reported by a consumer via call center representative and described the occurrence of product supply issue in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 1st May 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, not applicable after receiving Shingrix and unknown after receiving Shingrix, the patient experienced product supply issue and sickness. On an unknown date, the outcome of the product supply issue was unknown and the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingrix and Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had been trying to find any place from past two weeks, that could give their 2nd dose, but due to the problems making and delivering sufficient supply. The patient asked to the GSK, most definitely need to change how to deliver and how to manage such a limited supply. In particular, the GSK need to allocate it in such a way that ensure that those who receive the 1st dose were guaranteed the 2nd dose. Otherwise, people like me have wasted considerable money, received little benefit from the trauma of getting the shot and pretty much abandoned. The patient wanted to know, what supposed to do.
Sex: M
Vaccine: MENB
Symptoms: Asthenia, Depressed mood, Educational problem, Memory impairment, Mood swings
Clinical narrative: Memory problems; Lack of energy; Mood swings; feeling depressed/ sad; This case was reported by a other health professional and described the occurrence of memory disturbance in a male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced memory disturbance, loss of energy, mood swings and depressed mood. On an unknown date, the outcome of the memory disturbance, loss of energy, mood swings and depressed mood were unknown.   It was unknown if the reporter considered the memory disturbance, loss of energy, mood swings and depressed mood to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The reporter's son got the Bexsero before going to college. The patient was an amazing student and after getting this vaccine, since the reporter could not relate his situation to anything else, he started having memory problems, he had to drop the university due to this. After researching what might have been the cause, this was the only chain the reporter could tie with his lack of energy, mood swings, and memory problems. The reporter's son was an honor student at high school, learned Russian language by himself, aside from German, English and Spanish. The patient was in a Magnet Engineering program and at the time of reporting he was feeling more than depress and sad because he could not even solve a small problem.